BRK-B vs LIEN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
LIEN presents a classic 'value trap' profile, characterized by a very weak Piotroski F-Score of 2/9 indicating deteriorating fundamental health despite trading at a massive discount to its Graham Number ($20.9) and Intrinsic Value ($17.67). While the valuation metrics (P/E 6.32, P/B 0.69) are highly attractive, the technical trend is completely bearish (0/100) and the dividend payout ratio of 93.15% leaves almost no margin for error. The company shows steady revenue growth, but the lack of earnings momentum and poor health score suggest the market is pricing in significant underlying risk.
Compare Another Pair
Related Comparisons
BRK-B vs LIEN: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Chicago Atlantic BDC, Inc. (LIEN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.